Regarding the illustrated role of P2X7 receptors and platelet-mediated inflammation in EAE/MS, Alzheimer’s disease, and Parkinson’s disease, targeting purinergic receptors may provide novel therapeutic approaches in these devastating diseases. The gene discussed is P2RX2; the disease is early-onset autosomal dominant Alzheimer disease.